Logo image of ALCYB.PA

CYBERGUN SA (ALCYB.PA) Stock Fundamental Analysis

EPA:ALCYB - Euronext Paris - Matif - FR0014004QR6 - Common Stock - Currency: EUR

0.0005  +0 (+25%)

Fundamental Rating

1

Taking everything into account, ALCYB scores 1 out of 10 in our fundamental rating. ALCYB was compared to 14 industry peers in the Leisure Products industry. ALCYB may be in some trouble as it scores bad on both profitability and health. ALCYB does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

ALCYB had negative earnings in the past year.
In the past year ALCYB has reported a negative cash flow from operations.
ALCYB had negative earnings in 4 of the past 5 years.
ALCYB had a negative operating cash flow in each of the past 5 years.
ALCYB.PA Yearly Net Income VS EBIT VS OCF VS FCFALCYB.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10M -10M

1.2 Ratios

ALCYB has a Return On Assets of -27.57%. This is amonst the worse of the industry: ALCYB underperforms 92.86% of its industry peers.
Looking at the Return On Equity, with a value of -107.44%, ALCYB is doing worse than 92.86% of the companies in the same industry.
Industry RankSector Rank
ROA -27.57%
ROE -107.44%
ROIC N/A
ROA(3y)-12.03%
ROA(5y)-24.01%
ROE(3y)-37.16%
ROE(5y)-580.68%
ROIC(3y)N/A
ROIC(5y)N/A
ALCYB.PA Yearly ROA, ROE, ROICALCYB.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -500 -1K -1.5K -2K -2.5K

1.3 Margins

ALCYB has a Gross Margin of 40.24%. This is comparable to the rest of the industry: ALCYB outperforms 42.86% of its industry peers.
In the last couple of years the Gross Margin of ALCYB has grown nicely.
The Profit Margin and Operating Margin are not available for ALCYB so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 40.24%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y15.43%
GM growth 5Y25.11%
ALCYB.PA Yearly Profit, Operating, Gross MarginsALCYB.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 -20 40 -40

More info and screens

2

2. Health

2.1 Basic Checks

ALCYB does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, ALCYB has more shares outstanding
Compared to 5 years ago, ALCYB has more shares outstanding
ALCYB has a worse debt/assets ratio than last year.
ALCYB.PA Yearly Shares OutstandingALCYB.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M
ALCYB.PA Yearly Total Debt VS Total AssetsALCYB.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M

2.2 Solvency

ALCYB has an Altman-Z score of -0.09. This is a bad value and indicates that ALCYB is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of -0.09, ALCYB is not doing good in the industry: 92.86% of the companies in the same industry are doing better.
ALCYB has a Debt/Equity ratio of 0.13. This is a healthy value indicating a solid balance between debt and equity.
ALCYB has a better Debt to Equity ratio (0.13) than 85.71% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.13
Debt/FCF N/A
Altman-Z -0.09
ROIC/WACCN/A
WACC5.73%
ALCYB.PA Yearly LT Debt VS Equity VS FCFALCYB.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10M -10M 20M 30M

2.3 Liquidity

ALCYB has a Current Ratio of 1.01. This is a normal value and indicates that ALCYB is financially healthy and should not expect problems in meeting its short term obligations.
ALCYB's Current ratio of 1.01 is on the low side compared to the rest of the industry. ALCYB is outperformed by 85.71% of its industry peers.
ALCYB has a Quick Ratio of 1.01. This is a bad value and indicates that ALCYB is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.44, ALCYB is doing worse than 92.86% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.01
Quick Ratio 0.44
ALCYB.PA Yearly Current Assets VS Current LiabilitesALCYB.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M

More info and screens

1

3. Growth

3.1 Past

ALCYB shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -3372.58%.
The Revenue has decreased by -1.46% in the past year.
Measured over the past years, ALCYB shows a small growth in Revenue. The Revenue has been growing by 5.94% on average per year.
EPS 1Y (TTM)-3372.58%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-29.89%
Revenue 1Y (TTM)-1.46%
Revenue growth 3Y1.97%
Revenue growth 5Y5.94%
Sales Q2Q%-15.26%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ALCYB.PA Yearly Revenue VS EstimatesALCYB.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M 50M
ALCYB.PA Yearly EPS VS EstimatesALCYB.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 0 5M -5M -10M -15M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ALCYB. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ALCYB.PA Price Earnings VS Forward Price EarningsALCYB.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ALCYB.PA Per share dataALCYB.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.05 -0.1 -0.15

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ALCYB!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CYBERGUN SA

EPA:ALCYB (6/16/2025, 7:00:00 PM)

0.0005

+0 (+25%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryLeisure Products
Earnings (Last)10-31 2024-10-31
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap3.61M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.08
P/FCF N/A
P/OCF N/A
P/B 0.27
P/tB 0.69
EV/EBITDA N/A
EPS(TTM)-0.2
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0
FCFYN/A
OCF(TTM)0
OCFYN/A
SpS0.01
BVpS0
TBVpS0
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -27.57%
ROE -107.44%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 40.24%
FCFM N/A
ROA(3y)-12.03%
ROA(5y)-24.01%
ROE(3y)-37.16%
ROE(5y)-580.68%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y15.43%
GM growth 5Y25.11%
F-Score4
Asset Turnover0.81
Health
Industry RankSector Rank
Debt/Equity 0.13
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 33.45%
Cap/Sales 1.11%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.01
Quick Ratio 0.44
Altman-Z -0.09
F-Score4
WACC5.73%
ROIC/WACCN/A
Cap/Depr(3y)164.05%
Cap/Depr(5y)N/A
Cap/Sales(3y)6.65%
Cap/Sales(5y)5.97%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-3372.58%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-29.89%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-1.46%
Revenue growth 3Y1.97%
Revenue growth 5Y5.94%
Sales Q2Q%-15.26%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-495.78%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y66.97%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y62.3%
OCF growth 3YN/A
OCF growth 5YN/A